We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
62 hedge funds and large institutions have $508M invested in Evelo Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
650% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 2
158% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 12
27% more funds holding
Funds holding: 49 → 62 (+13)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% less capital invested
Capital invested by funds: $508M → $508M (-$397K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $168K
Holders
62
Holders Change
+13
Holders Change %
+26.53%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
15
Increased
31
Reduced
12
Closed
2
Calls
–
Puts
$168K
Net Calls
-$168K
Net Calls Change
-$168K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.5M |
| 2 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
+$12.4M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$11.1M |
| 4 |
BlackRock
New York
|
+$4.55M |
| 5 |
AG
Artal Group
Luxembourg
|
+$4.15M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$326K |
| 2 |
HSBC Holdings
London,
United Kingdom
|
-$145K |
| 3 |
MC
Mayo Clinic
Rochester,
Minnesota
|
-$79K |
| 4 |
Jane Street
New York
|
-$66.9K |
| 5 |
PCA
Peddock Capital Advisors
Braintree,
Massachusetts
|
-$44K |
